LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Running, not enrolling · Phase 2 · Has a placebo group

Conditions studied: Idiopathic Pulmonary Fibrosis

In brief

This study a randomized, double-blind, four arm study to evaluate the safety and efficacy of LYT-100 compared to pirfenidone or placebo in adults with Idiopathic Pulmonary Fibrosis.

Key facts

Study ID
NCT05321420
Run by
PureTech
People needed
240
Starts
2022-07-22
Expected to finish
2025-12-31
Last updated by the study team
2025-10-16

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.